SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Akselbrad Dikla Czaczkes

(Last)

(First)

(Middle)

C/O POLYPID LTD.

18 HASIVIM STREET

(Street)

PETACH TIKVA

495376

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
PolyPid Ltd. [ PYPD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	934	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock option (right to buy)	07/05/2016	04/05/2026	Ordinary Shares	279⁽¹⁾	$92.89	D
Stock option (right to buy)	08/25/2017	08/24/2026	Ordinary Shares	228⁽²⁾	$92.89	D
Stock option (right to buy)	03/21/2017	12/21/2026	Ordinary Shares	1,713⁽³⁾	$117.99	D
Stock option (right to buy)	08/08/2023	05/05/2033	Ordinary Shares	2,833⁽⁴⁾	$23.07	D
Stock option (right to buy)	10/01/2019	06/11/2030	Ordinary Shares	3,187⁽⁵⁾	$23.07	D
Stock option (right to buy)	08/09/2022	08/09/2032	Ordinary Shares	1,827⁽⁶⁾	$23.07	D
Stock option (right to buy)	07/01/2023	05/03/2032	Ordinary Shares	3,333⁽⁷⁾	$23.07	D
Stock option (right to buy)	08/07/2024	10/09/2033	Ordinary Shares	30,486⁽⁸⁾	$11.01	D
Stock option (right to buy)	08/06/2024	07/02/2034	Ordinary Shares	198,900⁽⁹⁾	$4.64	D
Stock option (right to buy)	06/09/2025	07/02/2034	Ordinary Shares	132,600⁽¹⁰⁾	$4.64	D
Stock option (right to buy)	08/12/2025	06/25/2035	Ordinary Shares	120,000⁽¹¹⁾	$2.67	D
Stock option (right to buy)	06/09/2025	06/25/2035	Ordinary Shares	80,000⁽¹²⁾	$2.67	D

Explanation of Responses:

1. The options were granted on April 5, 2016 and fully vested as of April 5, 2019.

2. The options were granted on August 24, 2016 and fully vested as of August 24, 2019.

3. The options were granted on December 21, 2016 and fully vested as of December 21, 2019.

4. The options were granted on May 5, 2023 and vest on a quarterly basis until May 5, 2027.

5. The options were granted on June 11, 2020 and fully vested as of July 1, 2022.

6. The options were granted on August 9, 2021 and vest on a quarterly basis beginning August 9, 2022 until August 9, 2025.

7. The options were granted on May 3, 2022 and fully vested as of April 1, 2025.

8. The options were granted on October 9, 2023 and vest on a quarterly basis beginning August 7, 2024 until August 7, 2027.

9. The options were granted on July 2, 2024 and vest on a quarterly basis until May 6, 2028.

10. The options were granted on July 2, 2024 and vest on a quarterly basis until May 6, 2026.

11. The options were granted on June 25, 2025 and vest on a quarterly basis until May 12, 2029.

12. The options were granted on June 25, 2025 and vest on a quarterly basis until May 12, 2027.

	/s/ Dikla Czaczkes Akselbrad	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Akselbrad Dikla Czaczkes